These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15886412)

  • 1. Pharmacokinetics and metabolism of nicotine.
    Tutka P; Mosiewicz J; Wielosz M
    Pharmacol Rep; 2005; 57(2):143-53. PubMed ID: 15886412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application.
    Levi M; Dempsey DA; Benowitz NL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):23-34. PubMed ID: 17206525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of nicotine and its metabolites I. Model development.
    Levi M; Dempsey DA; Benowitz NL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):5-21. PubMed ID: 17206524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence.
    Swan GE; Benowitz NL; Lessov CN; Jacob P; Tyndale RF; Wilhelmsen K
    Pharmacogenet Genomics; 2005 Feb; 15(2):115-25. PubMed ID: 15861035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.
    Mwenifumbo JC; Tyndale RF
    Pharmacogenomics; 2007 Oct; 8(10):1385-402. PubMed ID: 17979512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.
    Mwenifumbo JC; Lessov-Schlaggar CN; Zhou Q; Krasnow RE; Swan GE; Benowitz NL; Tyndale RF
    Clin Pharmacol Ther; 2008 Jan; 83(1):115-21. PubMed ID: 17522595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
    Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL
    Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
    Nakajima M
    Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of nicotine metabolism in twins: methods and procedures.
    Swan GE; Benowitz NL; Jacob P; Lessov CN; Tyndale RF; Wilhelmsen K; Krasnow RE; McElroy MR; Moore SE; Wambach M
    Twin Res; 2004 Oct; 7(5):435-48. PubMed ID: 15527659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of (-)-(S)-nicotine by guinea pig and rat brain: identification of cotinine.
    Jacob P; Ulgen M; Gorrod JW
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):391-4. PubMed ID: 9512939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
    Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female sex and oral contraceptive use accelerate nicotine metabolism.
    Benowitz NL; Lessov-Schlaggar CN; Swan GE; Jacob P
    Clin Pharmacol Ther; 2006 May; 79(5):480-8. PubMed ID: 16678549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics of nicotine dependence: relationship to pancreatic cancer.
    MacLeod SL; Chowdhury P
    World J Gastroenterol; 2006 Dec; 12(46):7433-9. PubMed ID: 17167830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior.
    Tyndale RF; Sellers EM
    Ther Drug Monit; 2002 Feb; 24(1):163-71. PubMed ID: 11805739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.
    Nakajima M; Kuroiwa Y; Yokoi T
    Drug Metab Rev; 2002 Nov; 34(4):865-77. PubMed ID: 12487152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatographic assay for N-glucuronidation of nicotine and cotinine in human liver microsomes.
    Nakajima M; Kwon JT; Tanaka E; Yokoi T
    Anal Biochem; 2002 Mar; 302(1):131-5. PubMed ID: 11846386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour.
    Tricker AR
    Toxicology; 2003 Feb; 183(1-3):151-73. PubMed ID: 12504349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.